A major breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial cancer inhibitor protein is frequently inactivated in many forms of tumors, causing uncontrolled https://throbsocial.com/story24114205/nanobodies-revive-the-p53-protein-a-potential-approach-for-cancer-treatment